OFEV vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. OFEV and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	OFEV	SIROLIMUS
Rating	72/100	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	NINTEDANIB ESYLATE	SIROLIMUS
Manufacturer	Boehringer Ingelheim	Apotex
Dosage forms	Capsule	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Idiopathic Pulmonary Fibrosis	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

ofev sirolimus

Rating

72/100

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

NINTEDANIB ESYLATE

SIROLIMUS

Manufacturer

Boehringer Ingelheim

Apotex

Dosage forms

Capsule

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Idiopathic Pulmonary Fibrosis

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is better-rated, Ofev or Sirolimus?

By our independent rating, Ofev scores higher — 3.6 vs 3.3 out of 5 for Sirolimus. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Ofev and Sirolimus?

Ofev contains Nintedanib Esylate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.